Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

about

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

Item

http://www.wikidata.org/entity/Q49340500

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prostate-specific antigen velo ...... n with genetic predisposition.

@en

Prostate-specific antigen velo ...... n with genetic predisposition.

@nl

type

Item

label

Prostate-specific antigen velo ...... n with genetic predisposition.

@en

Prostate-specific antigen velo ...... n with genetic predisposition.

@nl

prefLabel

Prostate-specific antigen velo ...... n with genetic predisposition.

@en

Prostate-specific antigen velo ...... n with genetic predisposition.

@nl

P1476

Prostate-specific antigen velo ...... n with genetic predisposition.

@en

P2093

Alan Donaldson

http://www.w3.org/2001/XMLSchema#string

Alex Henderson

http://www.w3.org/2001/XMLSchema#string

Alexander Dias

http://www.w3.org/2001/XMLSchema#string

Alison Falconer

http://www.w3.org/2001/XMLSchema#string

Allan Spigelman

http://www.w3.org/2001/XMLSchema#string

Amy Taylor

http://www.w3.org/2001/XMLSchema#string

Andrew Vickers

http://www.w3.org/2001/XMLSchema#string

Angela F Brady

http://www.w3.org/2001/XMLSchema#string

Anita V Mitra

http://www.w3.org/2001/XMLSchema#string

Anna C Newlin

http://www.w3.org/2001/XMLSchema#string

P2860

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Cancer risks in BRCA2 mutation carriers.

Cancer Incidence in BRCA1 mutation carriers.

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.

Germline BRCA1 mutations increase prostate cancer risk

P2888

bjc.2017.429

P304

266-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.429

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100167394

http://www.w3.org/2001/XMLSchema#string

P698

29301143

http://www.w3.org/2001/XMLSchema#string

P932

5785754

http://www.w3.org/2001/XMLSchema#string